2021-01-08,Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule
2021-01-08,"Ocugen Inc. to Present at CTIC, HC Wainwright and Noble Capital Investor Conferences"
2021-01-04,Why Ocugen Stock Is Crushing It Today
2020-12-31,Should You Sell Ocugen Stock Right Now?
2020-12-23,Ocugen Establishes Vaccine Scientific Advisory Board
2020-12-23,Is Ocugen Stock Still Worth Buying After Its 800%-Plus Rally? Analyst Weighs In
2020-12-23,"Company News for Dec 23, 2020"
2020-12-23,OCGN Stock: 5 Things for Investors to Know as Ocugen Soars 100%+
2020-12-22,"Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares"
2020-12-22,"Ocugen and Bharat Biotech to Co-Develop COVAXIN, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market"
2020-12-14,A Look Into Healthcare Sector Value Stocks
2020-12-10,Ocugen Inc. Announces Plan to Postpone Annual Meeting of Stockholders
2020-12-07,A Look Into Healthcare Sector Value Stocks
2020-12-02,Ocugen (OCGN) Soars: Stock Adds 6.6% in Session
2020-12-01,Leading Independent Proxy Firms ISS and Glass Lewis Recommend Ocugen Stockholders Vote FOR Reverse Stock Split and Authorized Shares Amendment Proposals
2020-11-27,CEO Dr. Shankar Musunuri to be Featured as a Panelist at Xconomys Xcelerating Life Sciences Virtual Event Discussing The Promise of Cell & Gene Therapies
2020-11-19,Ocugen (OCGN) Looks Good: Stock Adds 5.5% in Session
2020-11-09,5 Value Stocks To Watch In The Healthcare Sector
2020-11-06,Ocugen Provides Business Update and Third Quarter 2020 Financial Results
2020-10-29,Ocugen to Present at the GCFF Virtual Conference - Diversified Investing Strategies
2020-10-26,Overview Of Value Stocks In The Healthcare Sector
2020-10-22,CEO Dr. Shankar Musunuri to Discuss the Importance of Gene Therapy Strategic Partnerships at 4th Annual Gene Therapy for Rare Disorders Europe Conference
2020-10-16,Cantor Fitzgerald and Kristen Kluska to Host Zoom Fireside Chat with Ocugen
2020-10-12,Overview Of Value Stocks In The Healthcare Sector
2020-10-06,Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
2020-09-29,Ocugen to Participate in a Virtual Fireside Chat at the Chardan Genetic Medicines Conference
2020-09-28,A Look Into Healthcare Sector Value Stocks
2020-09-16,Ocugen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
2020-09-11,Why the Coronavirus May Have Disrupted Ocugen
2020-09-09,The Risk-Reward Ratio of Ocugen Stock Is Positive
2020-09-08,Ocugen Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
2020-09-03,"For Biopharma Ocugen, Think Speculation In Small Doses"
2020-09-03,Ocugen to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-08-28,Ocugen Needs Too Much Time and Too Much Cash
2020-08-28,Its Best to Avoid Ocugen Stock at the Moment
2020-08-28,Ocugen to Present at the LD 500 Virtual Investor Conference
2020-08-21,"Read This Before Selling Ocugen, Inc. (NASDAQ:OCGN) Shares"
2020-08-21,Theres a Reason Why Ocugen Is a Last Resort in Eye Care
2020-08-14,Ocugen Provides Business Update and Second Quarter 2020 Financial Results
2020-08-14,Execution Challenges Could Short-Circuit the Big Ocugen Stock Rally
2020-08-10,5 Value Stocks To Watch In The Healthcare Sector
2020-08-10,"Ocugen Receives Fourth FDA Orphan Drug Designation for the Same Product, OCU400 (AAV-NR2E3) Gene Therapy, for the Treatment of Another Key Inherited Retinal Disease (IRD), PDE6B Gene Mutation-Associated Retinal Diseases"
2020-08-07,There Are So Many Stocks to Buy  Ocugen Isnt One of Them
2020-08-06,"Ocugen to Host Conference Call on Friday, August 14 at 8:30 a.m. ET to Discuss Second Quarter 2020 Financial Results and Provide Business Update"
2020-07-27,Ocugen Granted FDA Orphan Drug Designation for OCU400 (AAV-hNR2E3) Gene Therapy for the Treatment of RHO Mutation-Associated Retinal Degenerative Disease
2020-07-21,Ocugen to Present at World Orphan Drug Congress USA 2020 Conference
2020-07-21,Ocugen to Present at World Orphan Drug Congress USA 2020 Conference
2020-06-12,"Ocugen Stock Is a Gamble, Not an Investment Opportunity"
2020-06-03,Ocugen Appoints Dr. Mohamed Genead as Chair of Retina Scientific Advisory Board
2020-06-01,Ocugen to Discontinue Phase 3 oGVHD Trial
2020-05-08,Ocugen Provides Business Update and First Quarter 2020 Financial Results
2020-04-22,Ocugen Announces Completion of Warrant Exchange
2020-04-07,Ocugen Appoints Kirsten Castillo and Prabhavathi Fernandes to Board of Directors
2020-03-27,Ocugen Provides Business Update and Full Year 2019 Financial Results
2020-03-27,Ocugen Inc to Host Earnings Call
2020-03-20,"Ocugen to Host Conference Call on Friday, March 27 at 8:30 a.m. ET to Discuss 2019 Financial Results and Provide Business Update"
2020-03-03,Nature Gene Therapy Publishes Preclinical Data of Ocugens OCU400 (NR2E3-AAV) Genetic Modifier to treat Retinitis Pigmentosa (RP)
2020-02-10,Ocugen to Present at NobleCon16 - Noble Capital Markets Sixteenth Annual Investor Conference
2020-01-03,3 Beaten-Up Biotech Stocks That Just Got More Enticing
2019-12-09,Ocugen Announces Completion of 50% of Enrollment of its Phase 3 Clinical Trial for ocular GVHD
2019-11-08,Ocugen Provides Business Update and Third Quarter 2019 Financial Highlights
2019-11-06,Ocugen Announces Warrant Restructuring
2019-11-04,Ocugen Announces Appointments to Retina Disease and Ocular Graft-Versus-Host Disease Scientific Advisory Boards
2019-10-25,"Ocugen to Host Conference Call on Friday, November 8 at 8:30 a.m. ET to Discuss Third Quarter Results and Recent Business Highlights"
2019-10-23,"Ocugen Appoints Jessica Crespo, CPA, as Controller"
2019-10-09,Ocugen Announces Share Repurchase Program
2019-10-07,Ocugen Announces Amendment to Asset Purchase Agreement
2019-10-01,"Ocugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial Officer"
2019-09-30,Ocugen to Present at Three Upcoming Conferences
2019-09-30,Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing
2019-09-30,Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics
